| AVAI BIO, INC. (TREN) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | ||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | ||||||||||||||||||||||||||||
| Operating Cash Flow | (50,827$) | (347,127$) | (371,547$) | (240,343$) | (187,500$) | (134,353$) | (826,055$) | (12,702$) | (136,522$) | (420,401$) | (59,726$) | (73,493$) | 60,251$ | (104,500$) | (24,001$) | 109,582$ | 50,347$ | (23,328$) | (5,883$) | (2,269$) | (8,484$) | (67,816$) | (5,596$) | ||||||||||||||||||||||||||
| Investing Cash Flow | 0$ | 0$ | (149,000$) | 0$ | (1,216$) | (1,432$) | 22,821$ | (98,974$) | (75,000$) | (97,400$) | 0$ | 0$ | 1,900$ | ||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 23,570$ | 305,534$ | 453,480$ | 169,352$ | 265,483$ | 135,651$ | 827,383$ | 12,865$ | 135,907$ | 421,363$ | 101,772$ | 162,153$ | (46,188$) | 109,774$ | (13,296$) | 16,195$ | 240,943$ | 121,190$ | 6,020$ | 1,080$ | 1,300$ | (10,961$) | 1,100$ | ||||||||||||||||||||||||||
| End Cash Position | 23,145$ | 50,402$ | 91,995$ | 10,062$ | 81,053$ | 3,070$ | 1,772$ | 444$ | 281$ | 896$ | 1,480$ | 518$ | 107,472$ | 18,812$ | 33,289$ | 29,514$ | 16,667$ | 12,825$ | 27,301$ | 498$ | 701$ | 102$ | 1,291$ | 8,475$ | |||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (50,827$) | (347,127$) | (371,547$) | (240,343$) | (187,500$) | (134,353$) | (826,055$) | (12,702$) | (136,522$) | (420,401$) | (59,726$) | (73,493$) | 60,251$ | (104,500$) | (24,001$) | 109,582$ | 50,347$ | (23,328$) | (5,883$) | (2,269$) | (8,484$) | (67,816$) | (5,596$) | ||||||||||||||||||||||||||